# Retatrutide vs GLP-1 drugs: weight loss meta-analysis

Source: https://pepvault.app/research/retatrutide-sinha-2025

Last updated: 2026-11-17

Use: © PepVault. Read and cite with a link. Copying, bulk scraping, rewriting or republishing is not permitted (https://pepvault.app/terms#content).

[Research](https://pepvault.app/research) [Retatrutide](https://pepvault.app/research#retatrutide)

Meta-analysis · people

# Retatrutide: top odds of 15% or more weight loss across 19 trials

Checked against the paper November 2026 Meta-analysis [Published by PepVault](https://pepvault.app/guides/how-we-research)

## The takeaway

In this pooled look at 19 trials, retatrutide led on reaching large weight loss but came with the highest side-effect risk of the drugs compared.

- **Kind:** Meta-analysis
- **Studied in:** People
- **Number studied:** 29506
- **Published:** 2025
- **Journal:** Obesity (Silver Spring)

## What they tested

The team set out to compare how well, and how safely, GLP-1 drugs, dual agonists and retatrutide help adults with overweight or obesity lose weight.

## How the study was done

A systematic review and Bayesian network meta-analysis, a method that pools and ranks results from many trials, of 19 randomized controlled trials in 29,506 adults with a BMI of 25 kg/m2 or more. It compared liraglutide, semaglutide, survodutide, tirzepatide, retatrutide and placebo on outcomes measured at 36 weeks or later.

<!--promo-->

Model. Individual results vary.

PepVault for iPhone

## Taking retatrutide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-flow&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## What they found

Retatrutide and the dual agonists each reached an average weight change of -11.0 kg, ahead of the GLP-1 drugs at -9.0 kg. For reaching 15% or more weight loss, retatrutide had an odds ratio (a measure of how much more likely an outcome is) of 54.6, followed by dual agonists at 16.4 and GLP-1 drugs at 9.0. Retatrutide also carried the highest risk of side effects. Having type 2 diabetes cut weight loss by 4.338 kg with GLP-1 drugs and by 5.016 kg with dual agonists, while groups with more women or a higher BMI did better.

## What it doesn’t show

This study pooled 19 earlier trials rather than running a new one, and it grouped GLP-1 drugs and dual agonists into classes. It covers only adults with a BMI of 25 kg/m2 or more, with outcomes at 36 weeks or later.

## The paper

Sinha and Ghosal Efficacy and Safety of GLP-1 Receptor Agonists, Dual Agonists, and Retatrutide for Weight Loss in Adults With Overweight or Obesity: A Bayesian NMA. Obesity (Silver Spring). 2025.

- [PubMed (PMID 40685589)](https://pubmed.ncbi.nlm.nih.gov/40685589/)
- [The paper (DOI 10.1002/oby.24360)](https://doi.org/10.1002/oby.24360)

## The compound

- [Retatrutide: how it works, half-life, studied range and evidence](https://pepvault.app/peptides/retatrutide)
- [Retatrutide dose guide](https://pepvault.app/lab/dosage/retatrutide)

## With this study

### Retatrutide

- [Retatrutide: the full reference](https://pepvault.app/peptides/retatrutide)
- [Retatrutide dose guide](https://pepvault.app/lab/dosage/retatrutide)

### Mixing charts

- [5 mg vial](https://pepvault.app/tools/reconstitution-calculator/retatrutide-5mg)
- [10 mg vial](https://pepvault.app/tools/reconstitution-calculator/retatrutide-10mg)
- [15 mg vial](https://pepvault.app/tools/reconstitution-calculator/retatrutide-15mg)
- [20 mg vial](https://pepvault.app/tools/reconstitution-calculator/retatrutide-20mg)
- [24 mg vial](https://pepvault.app/tools/reconstitution-calculator/retatrutide-24mg)
- [30 mg vial](https://pepvault.app/tools/reconstitution-calculator/retatrutide-30mg)
- [40 mg vial](https://pepvault.app/tools/reconstitution-calculator/retatrutide-40mg)
- [60 mg vial](https://pepvault.app/tools/reconstitution-calculator/retatrutide-60mg)

### Studies

- [Retatrutide: non-HDL cholesterol down up to 26.9% in phase 2 trials](https://pepvault.app/research/retatrutide-ruotolo-2026)
- [Retatrutide: up to 25.0% weight loss at 80 weeks in TRIUMPH-1](https://pepvault.app/research/retatrutide-triumph-1-2026)
- [All 12 studies](https://pepvault.app/research#retatrutide)

### Compared with

- [Retatrutide vs Tirzepatide](https://pepvault.app/peptides/compare/retatrutide-vs-tirzepatide)
- [Retatrutide vs Semaglutide](https://pepvault.app/peptides/compare/retatrutide-vs-semaglutide)
- [Survodutide vs Retatrutide](https://pepvault.app/peptides/compare/survodutide-vs-retatrutide)
- [Retatrutide vs Orforglipron](https://pepvault.app/peptides/compare/retatrutide-vs-orforglipron)
- [Retatrutide vs Mazdutide](https://pepvault.app/peptides/compare/retatrutide-vs-mazdutide)
- [Retatrutide vs Cagrilintide](https://pepvault.app/peptides/compare/retatrutide-vs-cagrilintide)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### Terms on this page

- [GLP-1](https://pepvault.app/glossary/glp-1)
- [Placebo](https://pepvault.app/glossary/placebo)
- [Randomized controlled trial (RCT)](https://pepvault.app/glossary/randomized-controlled-trial)
- [Meta-analysis](https://pepvault.app/glossary/meta-analysis)

## More studies on Retatrutide

- [Retatrutide: non-HDL cholesterol down up to 26.9% in phase 2 trials](https://pepvault.app/research/retatrutide-ruotolo-2026) Randomized trial · people · 2026
- [Retatrutide: up to 25.0% weight loss at 80 weeks in TRIUMPH-1](https://pepvault.app/research/retatrutide-triumph-1-2026) Randomized trial · people · 2026
- [Retatrutide: 26.1% fat mass loss at 36 weeks in type 2 diabetes](https://pepvault.app/research/retatrutide-coskun-2025) Randomized trial · people · 2025
- [Retatrutide: up to 82.4% less liver fat at 24 weeks in MASLD trial](https://pepvault.app/research/retatrutide-sanyal-2024) Randomized trial · people · 2024
- [Retatrutide: 24.2% weight loss at 48 weeks in the 12 mg arm](https://pepvault.app/research/retatrutide-jastreboff-2023) Randomized trial · people · 2023
- [Retatrutide: up to 8.96 kg placebo-adjusted weight loss in 12 weeks](https://pepvault.app/research/retatrutide-urva-2022) Randomized trial · people · 2022
- [Every study on Retatrutide](https://pepvault.app/research#retatrutide)

Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed November 2026. Spot an error? [feedback@pepvault.app](mailto:feedback@pepvault.app). [How we research](https://pepvault.app/guides/how-we-research). This page reports one study; it is not medical advice.

<!--promo-->

[Track it in the app](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-next&mt=8)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Taking retatrutide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-end&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

<!--promo-->

Model. Individual results vary.

PepVault for iPhone

## Taking retatrutide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-rail&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## With this study

### Retatrutide

- [Retatrutide: the full reference](https://pepvault.app/peptides/retatrutide)
- [Retatrutide dose guide](https://pepvault.app/lab/dosage/retatrutide)

### Mixing charts

- [5 mg vial](https://pepvault.app/tools/reconstitution-calculator/retatrutide-5mg)
- [10 mg vial](https://pepvault.app/tools/reconstitution-calculator/retatrutide-10mg)
- [15 mg vial](https://pepvault.app/tools/reconstitution-calculator/retatrutide-15mg)
- [20 mg vial](https://pepvault.app/tools/reconstitution-calculator/retatrutide-20mg)
- [24 mg vial](https://pepvault.app/tools/reconstitution-calculator/retatrutide-24mg)
- [30 mg vial](https://pepvault.app/tools/reconstitution-calculator/retatrutide-30mg)
- [40 mg vial](https://pepvault.app/tools/reconstitution-calculator/retatrutide-40mg)
- [60 mg vial](https://pepvault.app/tools/reconstitution-calculator/retatrutide-60mg)

### Studies

- [Retatrutide: non-HDL cholesterol down up to 26.9% in phase 2 trials](https://pepvault.app/research/retatrutide-ruotolo-2026)
- [Retatrutide: up to 25.0% weight loss at 80 weeks in TRIUMPH-1](https://pepvault.app/research/retatrutide-triumph-1-2026)
- [All 12 studies](https://pepvault.app/research#retatrutide)

### Compared with

- [Retatrutide vs Tirzepatide](https://pepvault.app/peptides/compare/retatrutide-vs-tirzepatide)
- [Retatrutide vs Semaglutide](https://pepvault.app/peptides/compare/retatrutide-vs-semaglutide)
- [Survodutide vs Retatrutide](https://pepvault.app/peptides/compare/survodutide-vs-retatrutide)
- [Retatrutide vs Orforglipron](https://pepvault.app/peptides/compare/retatrutide-vs-orforglipron)
- [Retatrutide vs Mazdutide](https://pepvault.app/peptides/compare/retatrutide-vs-mazdutide)
- [Retatrutide vs Cagrilintide](https://pepvault.app/peptides/compare/retatrutide-vs-cagrilintide)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### Terms on this page

- [GLP-1](https://pepvault.app/glossary/glp-1)
- [Placebo](https://pepvault.app/glossary/placebo)
- [Randomized controlled trial (RCT)](https://pepvault.app/glossary/randomized-controlled-trial)
- [Meta-analysis](https://pepvault.app/glossary/meta-analysis)

<!--promo-->

PepVault for iPhone

## Taking retatrutide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-sticky&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

## Research

- [All studies](https://pepvault.app/research)
- [Every study on Retatrutide](https://pepvault.app/research#retatrutide)

## The library

- [Retatrutide](https://pepvault.app/peptides/retatrutide)
- [Retatrutide dose guide](https://pepvault.app/lab/dosage/retatrutide)
- [The peptide reference library](https://pepvault.app/peptides)

## How we work

- [How we research](https://pepvault.app/guides/how-we-research)
- [How we check the library](https://pepvault.app/about#library)

PepVault is a research and tracking resource, not medical advice. Ranges are what studies used, never a dose for you. Brand names are trademarks of their owners; PepVault is independent of them.

PepVault is a private research and tracking tool, not medical advice. The information here is reference material from published literature and community use — always verify it and discuss any protocol with a qualified clinician before changing it.

© 2026 PepVault. Our text, data and tools may not be copied, scraped or republished without [permission](https://pepvault.app/terms#content).
